| Ident. | Authors (with country if any) | Title |
|---|
| 000009 (2008) |
Misato Hashizume [Japon] ; Masahiko Mihara [Japon] | Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling |
| 000012 (2005) |
Norihiro Nishimoto [Japon] | Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan |
| 000013 (2013) |
Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse] | Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis |
| 000014 (2012) |
Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon] | Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica |
| 000018 (2009) |
Luciana Marti [Brésil] ; Morton Scheinberg [Brésil] | Anti-interleukin 6: first line in rheumatoid arthritis? |
| 000020 (2011) |
Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni] | Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review |
| 000021 (2010) |
Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni] | Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis |
| 000023 (2009) |
Misato Hashizume [Japon] ; Yasushi Uchiyama [Japon] ; Naoto Horai [Japon] ; Naohisa Tomosugi [Japon] ; Masahiko Mihara [Japon] | Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production |
| 000024 (2012) |
A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France] | Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence? |
| 000025 (2014) |
Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon] | Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study) |
| 000027 (2010) |
Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon] | Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease |
| 000029 (2011) |
Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon] | Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma |
| 000030 (2010) |
Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie] | A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature |
| 000031 (2005) |
Shumpei Yokota [Japon] ; Takako Miyamae [Japon] ; Tomoyuki Imagawa [Japon] ; Shigeki Katakura [Japon] ; Rumiko Kurosawa [Japon] ; Masaaki Mori [Japon] | Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis |
| 000032 (2010) |
Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon] | Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis |
| 000039 (2011) |
Toshio Tanaka [Japon] ; Keisuke Hagihara [Japon] ; Yoshihito Shima [Japon] ; Masashi Narazaki [Japon] ; Atsushi Ogata [Japon] ; Atsushi Kumanogoh [Japon] | Tocilizumab, a humanized anti‐interleukin‐6 receptor antibody, for the treatment of autoimmune disorders |
| 000041 (2014) |
P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni] | A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab |
| 000043 (2009) |
Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon] | Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab |
| 000044 (2010) |
Yoh Arita [Japon] ; Yasushi Sakata [Japon] ; Takao Sudo [Japon] ; Tetsuo Maeda [Japon] ; Ken Matsuoka [Japon] ; Keito Tamai [Japon] ; Kaori Higuchi [Japon] ; Wataru Shioyama [Japon] ; Yoshikazu Nakaoka [Japon] ; Yuzuru Kanakura [Japon] ; Keiko Yamauchi-Takihara [Japon] | The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman’s disease |
| 000050 (2011) |
Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada | Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis |
| 000052 (2009) |
Miho Suzuki [Japon] ; Misato Hashizume [Japon] ; Hiroto Yoshida [Japon] ; Masahiko Mihara [Japon] | Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule |
